Company

CMB International

招银国际

CMB International (招银国际) is the investment arm of China Merchants Bank, active across venture capital and growth equity. The corpus shows it operating as both a lead and co-lead investor, with a 2023 Series A lead in synthetic-biology platform Yinjia Bio and a 2023 Series C co-lead alongside China Development Bank International in automotive supplier KH Automotive Technologies . Its portfolio spans biotech, synthetic biology, and advanced manufacturing: it has backed METiS Pharmaceuticals , Enhe Biotechnology (Bota Bio) , cell-therapy infrastructure player CytoNiche , and AI company Zhuiyi , among others. The fund also appears in a 2023 暗涌Waves survey of boutique investment banks deeply embedded in their sectors , suggesting it is recognized for sector-level specialization rather than purely financial exposure.

AI-generated — may contain errors, please verify.

CMB InternationalCompany
招银国际
渲染中…
Mentioned in 8 articles

Coverage